Tatva Chintan Pharma IPO allotted ₹150 crore worth of equity shares at ₹1083 per equity share to 22 anchor investors at upper price band. Total of 13,85,040 Equity Shares have been subscribed at ₹1083 per Equity Share. Its a good subscription from the Anchor Investors in Tatva Chintan Pharma IPO. The Tatva Chintan Pharma IPO to open on 16 July and closes on 20 July 2021. The price band is fixed at ₹1073 to ₹1083. The minimum bid is for 13 Shares (₹14,079) and maximum bid is 182 shares (₹197,106). Tatva Chintan Pharma IPO to raise ₹450 Crores via initial public offer. The Tatva Chintan Pharma IPO will get good response from the investors in all the categories as the results and the premium looks promising.
List of Tatva Chintan Pharma Anchor Investors:
The Bid/Offer Closing Date is on July 16, 2021. The Price Band for the Offer is from ₹1073 to ₹1083 per Equity Share. The Bids can be made for a minimum lot of 13 Equity Shares and in multiples of 13 Equity Shares thereafter. The Equity Shares are proposed to be listed on BSE and NSE (the "Stock Exchanges").
The Book Running Lead Managers of the IPO are ICICI Securities Ltd and JM Financial Consultants Private Limited.